Bulletin
Investor Alert

July 1, 2020, 2:41 a.m. EDT

Smith & Nephew sees Covid-19 hitting revenue

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

By Joe Hoppe

Smith & Nephew PLC said Wednesday that it expects underlying revenue for the second quarter to fall by around 29% on year due to the coronavirus pandemic, in line with prior expectations.

The medical-technology business said it was encouraged by improving performances as the quarter progressed, with underlying revenue down 47% in April, down 27% in May, and down 12% in June year-on-year. Smith & Nephew said performance was closely related to the easing of lockdown measures and with the resumption of elective surgeries, though there remains significant uncertainty and geographical variation.

Because of the hit in the first and second quarters, the company said that it expects its first-half trading margin will be substantially down on the prior year, and that it will provide an update on cost-cutting measures soon.

Smith & Nephew added that the damage from the pandemic was most pronounced in its orthopedic reconstruction, sports medicine and ear, nose and throat businesses, driven by lower levels of elective surgery. However, it also said its advanced wound management and trauma businesses have been more resilient.

Write to Joe Hoppe at joseph.hoppe@wsj.com

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.